# Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

> **NCT02922946** · PHASE1 · COMPLETED · sponsor: **Syndax Pharmaceuticals** · enrollment: 47 (actual)

## Conditions studied

- Volunteers
- Healthy Volunteers
- Human Volunteers
- Normal Volunteers

## Interventions

- **DRUG:** Entinostat

## Key facts

- **NCT ID:** NCT02922946
- **Lead sponsor:** Syndax Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-11
- **Primary completion:** 2017-05-20
- **Final completion:** 2017-06-26
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922946, "Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02922946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*